Notice Pursuant to the National Cooperative Research and Production Act of 1993-Medical CBRN Defense Consortium, 6821-6822 [2019-03527]

Download as PDF Federal Register / Vol. 84, No. 40 / Thursday, February 28, 2019 / Notices DEPARTMENT OF JUSTICE DEPARTMENT OF JUSTICE Antitrust Division Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993—Cooperative Research Group on Advanced Combustion Catalyst and Aftertreatment Technologies–II Notice Pursuant to the National Cooperative Research and Production Act of 1993—Interchangeable Virtual Instruments Foundation, Inc. Notice is hereby given that, on February 6, 2019, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), Southwest Research Institute— Cooperative Research Group on Aftertreatment Technologies (‘‘AC2AT– II’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing (1) the identities of the parties to the venture and (2) the nature and objectives of the venture. The notifications were filed for the purpose of invoking the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Pursuant to Section 6(b) of the Act, the identities of the parties to the venture are: Cummins, Inc., Columbus, IN; Denso Corporation, Aichi-ken, JAPAN; Isuzu, Tokyo, JAPAN; Komatsu Ltd., Tochigi-ken, JAPAN; and Weichai Power Co., Ltd., Weifang, PEOPLE’S REPUBLIC OF CHINA. The general area of planned activities of AC2AT–II is to develop the most cost effective solutions for future engine systems by identifying and addressing the opportunities and challenges for integration of catalysts and aftertreatment systems to engines with advanced combustion technologies. The proposed program incorporates projects focused in four distinct areas: (1) Development of aftertreatment simulation tools; (2) low temperature catalyst design; (3) advanced aftertreatment system integration; and (4) catalyzed urea water solution (UWS). Suzanne Morris, Chief, Premerger and Division Statistics Unit, Antitrust Division. khammond on DSKBBV9HB2PROD with NOTICES [FR Doc. 2019–03534 Filed 2–27–19; 8:45 am] BILLING CODE 4410–11–P Notice is hereby given that, on February 8, 2019, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), Interchangeable Virtual Instruments Foundation, Inc. (‘‘IVI Foundation’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Acqiris SA, Plan-lesOuates, SWITZERLAND, has been added as a party to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and IVI Foundation intends to file additional written notifications disclosing all changes in membership. On May 29, 2001, IVI Foundation filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6(b) of the Act on July 30, 2001 (66 FR 39336). The last notification was filed with the Department on June 14, 2018. A notice was published in the Federal Register pursuant to Section 6(b) of the Act on July 9, 2018 (83 FR 31775). Suzanne Morris, Chief, Premerger and Division Statistics Unit, Antitrust Division. [FR Doc. 2019–03529 Filed 2–27–19; 8:45 am] BILLING CODE 4410–11–P DEPARTMENT OF JUSTICE Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993—Cooperative Research Group on CHEDE-VII Notice is hereby given that, on February 6, 2019, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), Southwest Research Institute— VerDate Sep<11>2014 17:52 Feb 27, 2019 Jkt 247001 PO 00000 Frm 00057 Fmt 4703 Sfmt 4703 6821 Cooperative Research Group on CHEDEVII (‘‘CHEDE-VII’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, A&D Technology, Inc., Ann Arbor, MI, has been added as a party to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and CHEDE-VII intends to file additional written notifications disclosing all changes in membership. On January 6, 2016, CHEDE-VII filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6(b) of the Act on February 2, 2016 (81 FR 5484). The last notification was filed with the Department on November 8, 2017. A notice was published in the Federal Register pursuant to Section 6(b) of the Act on December 13, 2017 (82 FR 58653). Suzanne Morris, Chief, Premerger and Division Statistics Unit, Antitrust Division. [FR Doc. 2019–03528 Filed 2–27–19; 8:45 am] BILLING CODE 4410–11–P DEPARTMENT OF JUSTICE Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993—Medical CBRN Defense Consortium Notice is hereby given that, on January 28, 2019, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), Medical CBRN Defense Consortium (‘‘MCDC’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Altimmune, Inc., Gaithersburg, MD; Attogene Corp, Austin, TX; Autonomous Therapeutics, Inc., Brooklyn, NY; Government E:\FR\FM\28FEN1.SGM 28FEN1 6822 Federal Register / Vol. 84, No. 40 / Thursday, February 28, 2019 / Notices Scientific Source (GSS), Reston, VA; Lauren Sciences, New York, NY; Locus Biosciences, Morrisville, NC; Maxim Biomedical, Inc., Rockville, MD; MedsForAll, Inc., Seattle, WA; Pirouette Medical, Boston, MA; and University of Washington, Seattle, WA, have been added as parties to this venture. Also, AEQUOR, Inc., Oceanside, CA; Albany Molecular Research Inc. (AMRI), Albany, NY; Binergy Scientific, Inc., Atlanta, GA; New Mexico Institute of Mining and Technology, Socorro, NM; Polo Custom Products, Topeka, KS; and SENTEL Corporation, Alexandria, VA, have withdrawn as parties to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and MCDC intends to file additional written notifications disclosing all changes in membership. On November 13, 2015, MCDC filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6(b) of the Act on January 6, 2016 (81 FR 513). The last notification was filed with the Department on October 16, 2018. A notice was published in the Federal Register pursuant to Section 6(b) of the Act on November 7, 2018 (83 FR 55739). Suzanne Morris, Chief, Premerger and Division Statistics Unit, Antitrust Division. [FR Doc. 2019–03527 Filed 2–27–19; 8:45 am] BILLING CODE 4410–11–P DEPARTMENT OF JUSTICE Suzanne Morris, Chief, Premerger and Division Statistics Unit, Antitrust Division. Antitrust Division khammond on DSKBBV9HB2PROD with NOTICES Notice Pursuant to the National Cooperative Research and Production Act of 1993—National Spectrum Consortium Notice is hereby given that, on January 28, 2019, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), National Spectrum Consortium (‘‘NSC’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Enveil, Inc., Fulton, MD; VerDate Sep<11>2014 17:52 Feb 27, 2019 World Wide Technology, Inc. (WWT), St. Louis, MO; MegaWave Corporation, Worcester, MA; Athena Technologies, LLC, Orlando, FL; GBL Systems Corporation, Camarillo, CA; GPS Source, Inc., Pueblo, CO; JC3 LLC, Rockbridge Baths, VA; Kumu Networks, Sunnyvale, CA; IMSAR LLC, Springville, UT; and Parry Labs, LLC, Columbia, MD, have been added as parties to this venture. Also, Avcom of Virginia, Inc., N Chesterfield, VA; Florida International University, Miami, FL; Northeastern University, Boston, MA; Northwestern University, Evanston, IL; University at Buffalo, Buffalo, NY; Vanu Inc., Lexington, MA; Foundry Inc., Millersville, MD; OpenJAUS, LLC, Lake Mary, FL; University of California, Irvine, Irvine, CA; US Ignite, Inc., Washington, DC; Warrior Support Solutions, LLC, Hollis, NH; and COMINT Consulting LLC, Golden, CO, have withdrawn as parties to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and NSC intends to file additional written notifications disclosing all changes in membership. On September 24, 2014, NSC filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6(b) of the Act on November 4, 2014 (79 FR 65424). The last notification was filed with the Department on October 29, 2018. A notice was published in the Federal Register pursuant to Section 6(b) of the Act on November 7, 2018 (83 FR 55739). Jkt 247001 [FR Doc. 2019–03521 Filed 2–27–19; 8:45 am] BILLING CODE 4410–11–P DEPARTMENT OF JUSTICE Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993—PXI Systems Alliance, Inc. Notice is hereby given that, on February 8, 2019, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), PXI Systems Alliance, Inc. (‘‘PXI Systems’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade PO 00000 Frm 00058 Fmt 4703 Sfmt 4703 Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Computer Conversions Corporation, East Northport, NY; and Art Beijing Science & Tech. Dev. Co., Ltd., Beijing, PEOPLE’S REPUBLIC OF CHINA, have been added as parties to this venture. Also, StanTronic Instruments GmbH, Herrenberg, GERMANY, has withdrawn as a party to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and PXI Systems intends to file additional written notifications disclosing all changes in membership. On November 22, 2000, PXI Systems filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6(b) of the Act on March 8, 2001 (66 FR 13971). The last notification was filed with the Department on September 4, 2018. A notice was published in the Federal Register pursuant to Section 6(b) of the Act on September 20, 2018 (83 FR 47643). Suzanne Morris, Chief, Premerger and Division Statistics Unit, Antitrust Division. [FR Doc. 2019–03537 Filed 2–27–19; 8:45 am] BILLING CODE 4410–11–P DEPARTMENT OF JUSTICE Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993—Cooperative Research Group on Energy Storage System Evaluation and Safety II Notice is hereby given that, on February 11, 2019, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), Southwest Research Institute— Cooperative Research Group on Energy Storage System Evaluation and Safety II (‘‘EssEs-II’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages E:\FR\FM\28FEN1.SGM 28FEN1

Agencies

[Federal Register Volume 84, Number 40 (Thursday, February 28, 2019)]
[Notices]
[Pages 6821-6822]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-03527]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--Medical CBRN Defense Consortium

    Notice is hereby given that, on January 28, 2019, pursuant to 
Section 6(a) of the National Cooperative Research and Production Act of 
1993, 15 U.S.C. 4301 et seq. (``the Act''), Medical CBRN Defense 
Consortium (``MCDC'') has filed written notifications simultaneously 
with the Attorney General and the Federal Trade Commission disclosing 
changes in its membership. The notifications were filed for the purpose 
of extending the Act's provisions limiting the recovery of antitrust 
plaintiffs to actual damages under specified circumstances. 
Specifically, Altimmune, Inc., Gaithersburg, MD; Attogene Corp, Austin, 
TX; Autonomous Therapeutics, Inc., Brooklyn, NY; Government

[[Page 6822]]

Scientific Source (GSS), Reston, VA; Lauren Sciences, New York, NY; 
Locus Biosciences, Morrisville, NC; Maxim Biomedical, Inc., Rockville, 
MD; MedsForAll, Inc., Seattle, WA; Pirouette Medical, Boston, MA; and 
University of Washington, Seattle, WA, have been added as parties to 
this venture.
    Also, AEQUOR, Inc., Oceanside, CA; Albany Molecular Research Inc. 
(AMRI), Albany, NY; Binergy Scientific, Inc., Atlanta, GA; New Mexico 
Institute of Mining and Technology, Socorro, NM; Polo Custom Products, 
Topeka, KS; and SENTEL Corporation, Alexandria, VA, have withdrawn as 
parties to this venture.
    No other changes have been made in either the membership or planned 
activity of the group research project. Membership in this group 
research project remains open, and MCDC intends to file additional 
written notifications disclosing all changes in membership.
    On November 13, 2015, MCDC filed its original notification pursuant 
to Section 6(a) of the Act. The Department of Justice published a 
notice in the Federal Register pursuant to Section 6(b) of the Act on 
January 6, 2016 (81 FR 513).
    The last notification was filed with the Department on October 16, 
2018. A notice was published in the Federal Register pursuant to 
Section 6(b) of the Act on November 7, 2018 (83 FR 55739).

Suzanne Morris,
Chief, Premerger and Division Statistics Unit, Antitrust Division.
[FR Doc. 2019-03527 Filed 2-27-19; 8:45 am]
 BILLING CODE 4410-11-P